IDV vehicle

36F79718D0364

65 I B, DRUGS, PHARMACEUTICALS,&HEMATOLOGY RELATED PRODUCTS, FSS CONTRACT AWARD

Research the contractorView USAspending sourceSave to my pursuit research

Award details

Obligations, current value and potential value describe different measures; they are never added together.

FieldReported value
AgencyDepartment of Veterans Affairs
OfficeNAC FEDERAL SUPPLY SCHEDULE (36F797)
NAICS325412 — Pharmaceutical Preparation Manufacturing
PSC6505 — Drugs and Biologicals
Parent award / vehicleNot reported
Set-asideNO SET ASIDE USED.
Pricing typeFIXED PRICE WITH ECONOMIC PRICE ADJUSTMENT
Obligations$0
Current contract valueNot reported
Potential contract value / ceiling$2.0M
Start dateFeb 15, 2018
Current end dateNot available
Potential end dateNot available
Latest award activityAug 6, 2026
Source loadedSep 26, 2026

Funding and modification history

Showing the latest 70 of 70 loaded transactions. Negative values are deobligations.

DateModificationObligation changeDescription
Aug 6, 2026P00071$0CONTRACT CANCELLATION FOR FOLLOW ON OFFER AWARDED UNDER CONTRACT NUMBER 36F79726D0169.
Jul 24, 2026P00070$0NDC CHANGES
Jul 20, 2026P00069$0TEMPORARY CONTRACT EXTENSION
May 28, 2026P00068$0TEMPORARY PRICE REDUCTION
Mar 30, 2026P00067$0PRODUCT ADDITION
Feb 19, 2026P00065$0PRODUCT ADDITION AND PERMANENT PRICE DECREASE
Feb 19, 2026P00066$0VOLUNTARY PERMANENT PRICE REDUCTION
Jan 27, 2026P00064$0TEMPORARY CONTRACT EXTENSION
Dec 1, 2025P00063$02026 PUBLIC LAW PRICING UPDATE
Oct 17, 2025P00062$0PERMANENT PRICE REDUCTION & ECONOMIC PRICE REDUCTION
Jul 17, 2025P00061$06-MONTH TEMPORARY CONTRACT EXTENSION
Jun 9, 2025P00060$065IB: SIN 42-2B - PERMANENT PRICE REDUCTION - LOG# 25-P0232
Apr 29, 2025P00059$0PERMANENT PRICE REDUCTION
Apr 1, 2025P00056$0PERMANENT PRICE REDUCTIONS
Apr 1, 2025P00058$0PRODUCT DELETION
Mar 19, 2025P00057$0PRODUCT ADDITIONS
Feb 12, 2025P00055$0PRODUCT DELETION
Jan 24, 2025P00054$06-MONTH CONTRACT EXTENSION
Dec 23, 2024P00053$0POC CHANGE
Nov 26, 2024P00052$0FSS
Sep 12, 2024P00051$0FSS
Aug 8, 2024P00050$0FSS
May 23, 2024P00049$0FSS
May 22, 2024P00048$0FSS
Apr 16, 2024P00047$0FSS
Apr 12, 2024P00046$0FSS
Mar 26, 2024P00044$0FSS
Mar 26, 2024P00045$0FSS
Jan 25, 2024P00043$0ADMINISTRATIVE CHANGE
Dec 12, 2023P00041$02024 PUBLIC LAW
Dec 12, 2023P00042$0TEMPORARY CONTRACT EXTENSION
Nov 9, 2023P00039$0FSS
Nov 6, 2023P00040$0FSS
Aug 30, 2023P00038$0FSS
May 15, 2023P00037$0PRODUCT ADDITION
Apr 21, 2023P00036$0PERMANENT PRICE REDUCTION
Jan 20, 2023P00035$0TEMPORARY PRICE REDUCTION
Jan 18, 2023P00034$0TEMPORARY CONTRACT EXTENSION
Nov 28, 2022P00033$0PUBLIC LAW 2023
Oct 25, 2022P00032$0TEMPORARY PRICE REDUCTION
Sep 30, 2022P00031$0TEMPORARY PRICE REDUCTION MODIFICATION.
Sep 20, 2022P00030$0PRODUCT ADDITION
Aug 3, 2022P00029$0PRODUCT ADDITION
Jun 29, 2022P00028$0PERMANENT PRICE DECREASE
Jun 16, 2022P00027$0PRODUCT ADDITION
Apr 20, 2022P00026$0PRODUCT ADDITION
Feb 24, 2022P00025$0PRODUCT ADDITION
Dec 22, 2021P00024$0PUBLIC LAW PRICING UPDATE
Oct 19, 2021P00023$0PERMANENT PRICE REDUCTION
Oct 1, 2021P00022$0PRODUCT ADDITION
Sep 24, 2021P00021$0PERMANENT PRICE DECREASE
Jun 29, 2021P00018$0ADMINISTRATIVE CHANGE
Jun 9, 2021P00017$0PERMANENT PRICE REDUCTION
Apr 28, 2021P00016$0PRODUCT ADDITION
Apr 27, 2021P00015$0PERMANENT PRICE REDUCTION
Dec 17, 2020P00014$0PUBLIC LAW INCREASE
Dec 9, 2020P00013$065IB - PRODUCT ADDITIONS 42-2B
Nov 24, 2020P00012$0PERMANENT PRICE REDUCTION
Nov 3, 2020P00011$0PRODUCT ADDITION
Aug 25, 2020P00010$0PERMANENT PRICE REDUCTION
Aug 24, 2020P00009$0PRODUCT ADDITION
Aug 12, 2020P00008$0PERMANENT PRICE REDUCTION
May 29, 2020P00007$0PRODUCT ADDITION
Apr 8, 2020P00006$0PRODUCT ADDITION OF PERIACTIN (2).
Dec 19, 2019P00005$042-2B PRODUCTION ADDITIONS - 13 NDCS
Dec 11, 2019P00004$0PUBLIC LAW - PRICE UPDATES
Jan 17, 2019P00003$0PERMANENT PRICE REDUCTION ON CLOZAPINE (VERSACLOZ).
Dec 27, 2018P00002$0PUBLIC LAW 2019.
Jun 20, 2018P00001$0NDC CHANGE ON VERSACIOZ.
Feb 7, 20180$065 I B, DRUGS, PHARMACEUTICALS,&HEMATOLOGY RELATED PRODUCTS, FSS CONTRACT AWARD

Research next steps

  1. Check the stated set-aside against the solicitation and current certifications.
  2. Review the award scope and buyer evidence before making a bid/no-bid decision.